PMC full text:
J Community Health. Author manuscript; available in PMC 2013 Oct 19.
Published in final edited form as:
J Community Health. 2008 Jun; 33(3): 126–133.
doi: 10.1007/s10900-007-9083-3Table 2
Characteristics of persons by whether or not they had a provider evaluation that included a discussion of treatment*
| No discussion of treatment with provider (n=309) | Discussed treatment with provider (n=86) | P-value | |
|---|---|---|---|
| Median age (yrs) | 54 (50-58) | 50 (46-55) | 0.25 |
| Male | 221 (72) | 66 (77) | 0.34 |
| African-American | 291 (94) | 82 (95) | 0.68 |
| HIV/HCV co-infected | 90 (29) | 32 (37) | 0.15 |
| HCV genotype 1 | 205 (96) | 68 (97) | 0.46 |
| Any drug use | 143 (46) | 26 (30) | <0.01 |
| Injection drug use | 96 (31) | 16 (19) | 0.02 |
| Methadone maintenance | 75 (24) | 15 (17) | 0.18 |
| Alcohol use | 128 (41) | 25 (29) | 0.04 |
| Homeless | 38 (12) | 9 (10) | 0.64 |
| Incarcerated | 33 (11) | 8 (9) | 0.70 |
| Health insurance | 182 (59) | 71 (83) | <0.0001 |
| Depression† | 15 (16) | 5 (22) | 0.54 |
| On medication for depression | 44 (14) | 22 (26) | 0.01 |
| Inpatient hospitalization | 39 (13) | 12 (14) | 0.74 |
| Outpatient visit | 155 (50) | 62 (72) | <0.001 |
| Emergency room visit | 80 (26) | 24 (28) | 0.71 |
| Liver biopsy | |||
| No | 202 (66) | 30 (35) | <0.0001 |
| Only through the ALIVE study | 62 (20) | 25 (29) | |
| Received biopsy outside the ALIVE study | 40 (13) | 31 (36) | |
| Self-perceived disease severity‡ | |||
| Low | 93 (36) | 28 (38) | 0.90 |
| Moderate | 136 (52) | 36(49) | |
| High | 33 (13) | 9 (12) | |
| Aware that treatment can cure HCV | 60 (19) | 28 (33) | 0.01 |
*The sample includes 418 individuals who reported that they had heard of treatment and who had data to characterize whether they had been offered treatment (e.g. 23 have missing data) P values from chi square tests for categorical variables and Mann-Whitney tests for continuous variables
†Depression characterized as CES-D Scale ≥23; Only available for 116 participants
‡Participants were asked to estimate the likelihood of developing cirrhosis in the next 10 years